depression and semaglutide Weight loss drugs linked to lower likelihood of anxiety diagnoses: Study Weight management drug does not

Lead author Professor Sunil Badve, Professorial Fellow at The George Institute for Global Health and UNSW Sydney said the study expanded current knowledge about this class of drugs in key areas, including benefits in people with CKD, and in people with and without diabetes

They can contribute to modest body-composition changes, typically reducing visceral fat and improving muscle tone over 2 to 3 months of use

The injection process is straightforward, and the long half-life means you have flexibility in timing without losing effectiveness

Welcome to the ECHAR network

For any other use, please contact us

Who Is a Good Candidate Medical weight loss with GLP-1 medications is appropriate for adults (18 and older) with a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol